US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals

Watchlist
  • 59.730
  • -0.040-0.07%
Close Nov 12 16:00 ET
  • 59.730
  • 0.0000.00%
Post 16:20 ET
2.33BMarket Cap-26546P/E (TTM)

Longboard Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
63.94%25.64M
51.40%18.11M
26.70%56.76M
32.80%15.57M
14.29%13.58M
35.23%15.64M
24.35%11.96M
60.92%44.8M
33.35%11.73M
87.00%11.88M
Selling and administrative expenses
67.35%5.2M
43.94%4.94M
28.02%13.01M
33.19%3.38M
24.71%3.09M
17.38%3.11M
37.33%3.43M
25.98%10.16M
4.45%2.53M
9.68%2.48M
-General and administrative expense
67.35%5.2M
43.94%4.94M
28.02%13.01M
33.19%3.38M
24.71%3.09M
17.38%3.11M
37.33%3.43M
25.98%10.16M
4.45%2.53M
9.68%2.48M
Research and development costs
63.09%20.45M
54.40%13.17M
26.31%43.75M
32.69%12.2M
11.54%10.49M
40.52%12.54M
19.79%8.53M
75.17%34.64M
44.36%9.19M
129.73%9.4M
Operating profit
-63.94%-25.64M
-51.40%-18.11M
-26.70%-56.76M
-32.80%-15.57M
-14.29%-13.58M
-35.23%-15.64M
-24.35%-11.96M
-60.92%-44.8M
-33.35%-11.73M
-87.00%-11.88M
Net non-operating interest income expense
491.67%3.91M
507.17%3.13M
187.34%2.41M
45.01%567K
130.66%662K
419.69%660K
1,512.50%516K
1,207.81%837K
1,529.17%391K
1,147.83%287K
Non-operating interest income
491.67%3.91M
507.17%3.13M
187.34%2.41M
45.01%567K
130.66%662K
419.69%660K
1,512.50%516K
1,207.81%837K
1,529.17%391K
1,147.83%287K
Other net income (expense)
-176.47%-47K
10.00%-9K
-525.00%-68K
-200.00%-27K
-1,500.00%-14K
-151.52%-17K
-11.11%-10K
172.73%16K
-200.00%-9K
107.69%1K
Other non- operating income (expenses)
-176.47%-47K
10.00%-9K
-525.00%-68K
-200.00%-27K
-1,500.00%-14K
-151.52%-17K
-11.11%-10K
172.73%16K
-200.00%-9K
107.69%1K
Income before tax
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
Income tax
Net income
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
Net income continuous Operations
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
Minority interest income
Net income attributable to the parent company
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
Basic earnings per share
13.85%-0.56
25.00%-0.42
6.64%-2.39
6.06%-0.62
19.12%-0.55
2.99%-0.65
0.00%-0.56
-32.64%-2.56
-26.92%-0.66
-78.95%-0.68
Diluted earnings per share
13.85%-0.56
25.00%-0.42
6.64%-2.39
6.06%-0.62
19.12%-0.55
2.99%-0.65
0.30%-0.56
-32.64%-2.56
-26.92%-0.66
-78.95%-0.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 63.94%25.64M51.40%18.11M26.70%56.76M32.80%15.57M14.29%13.58M35.23%15.64M24.35%11.96M60.92%44.8M33.35%11.73M87.00%11.88M
Selling and administrative expenses 67.35%5.2M43.94%4.94M28.02%13.01M33.19%3.38M24.71%3.09M17.38%3.11M37.33%3.43M25.98%10.16M4.45%2.53M9.68%2.48M
-General and administrative expense 67.35%5.2M43.94%4.94M28.02%13.01M33.19%3.38M24.71%3.09M17.38%3.11M37.33%3.43M25.98%10.16M4.45%2.53M9.68%2.48M
Research and development costs 63.09%20.45M54.40%13.17M26.31%43.75M32.69%12.2M11.54%10.49M40.52%12.54M19.79%8.53M75.17%34.64M44.36%9.19M129.73%9.4M
Operating profit -63.94%-25.64M-51.40%-18.11M-26.70%-56.76M-32.80%-15.57M-14.29%-13.58M-35.23%-15.64M-24.35%-11.96M-60.92%-44.8M-33.35%-11.73M-87.00%-11.88M
Net non-operating interest income expense 491.67%3.91M507.17%3.13M187.34%2.41M45.01%567K130.66%662K419.69%660K1,512.50%516K1,207.81%837K1,529.17%391K1,147.83%287K
Non-operating interest income 491.67%3.91M507.17%3.13M187.34%2.41M45.01%567K130.66%662K419.69%660K1,512.50%516K1,207.81%837K1,529.17%391K1,147.83%287K
Other net income (expense) -176.47%-47K10.00%-9K-525.00%-68K-200.00%-27K-1,500.00%-14K-151.52%-17K-11.11%-10K172.73%16K-200.00%-9K107.69%1K
Other non- operating income (expenses) -176.47%-47K10.00%-9K-525.00%-68K-200.00%-27K-1,500.00%-14K-151.52%-17K-11.11%-10K172.73%16K-200.00%-9K107.69%1K
Income before tax -45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M
Income tax
Net income -45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M
Net income continuous Operations -45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M
Minority interest income
Net income attributable to the parent company -45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M
Basic earnings per share 13.85%-0.5625.00%-0.426.64%-2.396.06%-0.6219.12%-0.552.99%-0.650.00%-0.56-32.64%-2.56-26.92%-0.66-78.95%-0.68
Diluted earnings per share 13.85%-0.5625.00%-0.426.64%-2.396.06%-0.6219.12%-0.552.99%-0.650.30%-0.56-32.64%-2.56-26.92%-0.66-78.95%-0.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data